News - Pharmaceuticals
The weight of the wait: GLP-1 boom hits PBS roadblock
More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
MoreNews - Pharmaceuticals
The human faces rewriting Australia’s most common rare disease, cystic fibrosis
New national data from the Australian Cystic Fibrosis Data Registry (ACFDR) has revealed a significant shift in the trajectory of […]
MoreNews - Pharmaceuticals
‘We must transcend silos in service of patients,’ says AbbVie VP & GM
Healthcare leadership is being tested in ways that extends well beyond science, policy or commercial performance. In this Health Industry […]
MoreNews - Pharmaceuticals
Policy reforms fail as Australia slips to the bottom for health outcomes
Australians can expect to live to 83 years of age, yet a new international study reveals that almost 14 of […]
MoreNews - Pharmaceuticals
PBS backs first targeted therapy for rare brain cancer in over two decades
Australians living with a rare, incurable form of brain cancer will gain subsidised access to the first targeted therapy for […]
MoreNews - Pharmaceuticals
Biologics for paediatric Crohn’s PBS listed to address ‘unnecessary suffering’
Children with severe Crohn’s disease will now have earlier access to first-line biologic therapies through the Pharmaceutical Benefits Scheme (PBS), […]
MoreNews - Pharmaceuticals
Telix patent fight over Novartis’ Pluvicto heads toward 2027 trial
The Federal Court of Australia has mapped out the next phase of a closely watched patent dispute between Melbourne-based Telix […]
MoreNews - Pharmaceuticals
First chemo-free combination therapy PBS listed in follicular lymphoma
Australians diagnosed with relapsed or refractory follicular lymphoma (FL) will now have access to the first chemotherapy-free, targeted combination treatment […]
MoreRecent Posts in Pharma, MedTech & Biotech
New vaccine guidelines risk further decline in immunisation
August 11, 2026
in News - Pharmaceuticals
The weight of the wait: GLP-1 boom hits PBS roadblock
August 11, 2026
in News - Pharmaceuticals
As insurer blame game escalates, patients miss out on the promise of private health
August 11, 2026
in News - MedTech & Diagnostics
David Henderson appointed Takeda Oceania Country Head
August 10, 2026
in Leadership & Management
GBMA puts medicine shortages on the table as strategic agreement talks begin
August 10, 2026
in News - Pharmaceuticals
Australia sets a new course for prostate cancer detection
August 10, 2026
in News - MedTech & Diagnostics
IVF success rates climb as ART sector faces major accreditation overhaul
August 10, 2026
in News - Pharmaceuticals
‘Get comfortable being uncomfortable,’ urges Medtronic VP and Managing Director
August 7, 2026
in News - MedTech & Diagnostics
Follow Us
Partner with us
News - Pharmaceuticals
New vaccine guidelines risk further decline in immunisation
The intensifying political and public scrutiny of Dr Anthony Fauci has become emblematic of a wider struggle over trust in […]
MoreNews - Pharmaceuticals
The weight of the wait: GLP-1 boom hits PBS roadblock
More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]
MoreNews - MedTech & Diagnostics
As insurer blame game escalates, patients miss out on the promise of private health
The Age and Sydney Morning Herald’s investigation into the Prescribed List (PL) and the pricing of medical devices has drawn […]
MoreLeadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
More